Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate–chitosan microparticles

References

• Donbrow M. (1992). Microcapsules and nanoparticles in medicine and pharmacy, New York: CRC Press, Inc, 2–14.
   Google Scholar
• Tonessen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm, 28:621–30.
   PubMed Web of Science ®Google Scholar
• Galeone M, Nizzola L, Cacioli D, Mosie G. (1981). In vitro demonstration of delivery mechanism from sustained release pellets. Curr Ther Res, 29:217–34.
   Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Wilding IR. (1991). Variation in gastrointestinal transit of pharmaceutical dosage form in healthy subject. Pharm Res, 18:360–4.
   Google Scholar
• Clarke GM, Newton JM, Short MD. (1993). Gastro intestinal transit of pellets of differing size and density. Int J Pharm, 10:81–92.
   Google Scholar
• Fernandez-Hervas MJ, Holgado MA, Fini A, Fell JT. (1998). In vitro evaluation of alginate beads of diclofenac salt. Int J Pharm, 163:23–34.
   Web of Science ®Google Scholar
• Agnihotri SA, Aminabhavi TM. (2004). Formulation and valuation of novel tableted chitosan microparticles for the controlled release of clozapine. J Microencapsul, 21:709–18.
   PubMed Web of Science ®Google Scholar
• Bechgaard H, Ladefoged K. (1978). Distribution of pellets in the gastro-intestinal tract. The influence on transit-time exerted by the density or diameter of pellets. J Pharm Pharmacol, 30:690–2.
   PubMed Web of Science ®Google Scholar
• Gaserod O, Sannes A, Skjak-Braek G. (1999). Microcapsules of alginate–chitosan. II. A study of capsule stability and permeability. Biomaterials, 20:773–83.
   PubMed Web of Science ®Google Scholar
• McDowell RH. (1986). Properties of alginates, 5th ed. London: Kelco International.
   Google Scholar
• Acarturk F, Takka S. (1999). Calcium alginate microparticles for oral administration. II. Effect of formulation factors on drug release and drug entrapment efficiency. J Microencapsul, 16:291–301.
   PubMed Web of Science ®Google Scholar
• Takka S, Acarturk F. (1999). Calcium alginate microparticles for oral administration: I. Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul, 16:275–90.
   PubMed Web of Science ®Google Scholar
• Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, . (2007). Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm, 342:124–36.
   PubMed Web of Science ®Google Scholar
• Murata Y, Nakada K, Miyamoto E, Kawashima S, Seo SH. (1993). Influence of erosion of calcium-induced alginate gel matrix on the release of brilliant blue. J Control Release, 23:21–6.
   Web of Science ®Google Scholar
• Buthe A, Hartmeier W, Ansorge-Schumacher MB. (2004). Novel solvent-based method for preparation of alginate beads with improved roundness and predictable size. J Microencapsul, 21:865–76.
   PubMed Web of Science ®Google Scholar
• Yotsuyanagi T, Yoshioka I, Segi N, Ikeda K. (1991). Acid-induced and calcium-induced gelation of alginic acid: Bead formation and pH dependent swelling. Chem Pharm Bull, 39:1072–4.
   Web of Science ®Google Scholar
• Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. (2002). Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 232:225–34.
   PubMed Web of Science ®Google Scholar
• Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2005). Papain entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network, modeling. AAPS PharmSciTech, 6:209–22.
   PubMed Web of Science ®Google Scholar
• Roberts GAF. (1992). Chitin chemistry. Houndmills: Macmillan Press, 1–50.
   Google Scholar
• Gaserod O, Smidsrod O, Skjak-Braek G. (1998). Microcapsules of alginate–chitosan. I. A quantitative study of the interaction between alginate and chitosan. Biomaterials, 19:1815–25.
   PubMed Web of Science ®Google Scholar
• Kas HS. (1997). Chitosan: Properties, preparation and application to microparticulate systems. J Microencapsul, 14:689–711.
   PubMed Web of Science ®Google Scholar
• Singla AK, Chawla M. (2001). Chitosan: Some pharmaceutical and biological aspects—an update. J Pharm Pharmacol, 53:1047–67.
   PubMed Web of Science ®Google Scholar
• Kato Y, Onish H, Machida Y. (2003). Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol, l4:303–9.
   Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm, 274:1–33.
   PubMed Web of Science ®Google Scholar
• Overgaard S, Scharer JM, Moo-Young M, Bols NC. (1991). Immobilization of hybridoma cells in chitosan alginate beads. Can J Chem Eng, 69:439–43.
   Web of Science ®Google Scholar
• Huguet ML, Groboillot A, Neufeldt RJ, Poncelet D, Dellacherie E. (1994). Haemoglobin encapsulation in chitosan/calcium alginate beads. J Appl Polym Sci, 51:1427–32.
   Web of Science ®Google Scholar
• Huguet ML, Neufeld RJ, Dellacherie E. (1996). Calcium–alginate beads coated with polycationic polymers: Comparison of chitosan and DEAE-dextran. Process Biochem, 39:347–53.
   Google Scholar
• Lee KY, Park WH, Ha WS. (1997). Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. J Appl Polym Sci, 63:425–32.
   Web of Science ®Google Scholar
• Mladenovska K, Cruaud O, Richomme P, Belamie E, Raicki RS, Venier-Julienne MC. (2007b). 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int J Pharm, 345:59–69.
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science, 210:908–10.
   PubMed Web of Science ®Google Scholar
• Cekic N, Savic S, Milic J, Savic M, Jovic Ž, Malešević M. (2007). Phenytoin-loaded alginate and alginate–chitosan microparticles: Preparation, encapsulation efficiency and release behaviour. Drug Delivery, 14:483–90.
   PubMedGoogle Scholar
• Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. (2004). Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav, 5:301–7.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Takayama K, Machida Y, Nagai T. (1990). Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm, 61:35–41.
   Web of Science ®Google Scholar
• Polk A, Amsden B, De Yao K, Peng T, Goosena A. (1994). Calcium alginate matrices for oral multiple administration: IV. Release characteristics in different media. Int J Pharm, 112:241–8.
   Google Scholar
• Shu XZ, Zhu KJ. (2002). The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: The preparation method effect. Eur J Pharm Biopharm, 53:193–201.
   PubMed Web of Science ®Google Scholar
• Filipovic-Grcic J, Becirevic-Lacan M, Shalko N, Jalsenjak I. (1996). Chitosan microspheres of nifedipine and nifedipine—cyclodextrin inclusion complexes. Int J Pharm, 135:183–90.
   Web of Science ®Google Scholar
• Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215–32.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Akbuga J. (1999). Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. J Microencapsul, 16:195–203.
   PubMed Web of Science ®Google Scholar